Novel therapeutic agents that modulate estrogen receptors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/42 (2006.01) A61K 31/535 (2006.01) A61K 38/00 (2006.01) A61K 38/02 (2006.01) A61K 38/16 (2006.01) A61K 39/00 (2006.01) A61K 39/395 (2006.01) A61K 39/44 (2006.01) A61K 51/00 (2006.01) C07B 61/00 (2006.01) C07C 215/60 (2006.01) C07C 217/08 (2006.01) C07C 323/62 (2006.01) C07D 211/42 (2006.01) C07D 211/56 (2006.01) C07D 213/74 (2006.01) C07D 213/80 (2006.01) C07D 263/32 (2006.01) C07D 263/34 (2006.01) C07D 265/30 (2006.01) C07D 265/32 (2006.01) C07D 271/06 (2006.01) C07D 277/24 (2006.01) C07D 277/28 (2

Patent

CA 2319497

Disclosed are novel multi-binding compounds (agents) which bind estrogen receptors. The compounds of this invention comprise a plurality of ligands each of which can bind to such receptors thereby modulating the biological processes/functions thereof. Each of the ligands is covalently attached to a linker or linkers which may be the same or different to provide for the multi- binding compound. The linker is selected such that the multi-binding compound so constructed demonstrates increased modulation of the biological processes mediated by the estrogen receptors.

L'invention se rapporte à de nouveaux composés (agents) à liaisons multiples, qui se lient aux récepteurs d'oestrogènes. Ces composés comprennent plusieurs ligands susceptibles de se lier chacun à ces récepteurs dans le but de moduler leurs fonctions/processus biologiques. Chacun de ces ligands est lié de manière covalente à une ou plusieurs séquences de liaison pouvant être identiques ou différentes de manière à former le composé à liaisons multiples. Ladite séquence de liaison est sélectionnée de sorte que le composé à liaisons multiples ainsi formé présente une activité accrue de modulation des processus biologiques dont la médiation est assurée par le récepteur d'oestrogènes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel therapeutic agents that modulate estrogen receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel therapeutic agents that modulate estrogen receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel therapeutic agents that modulate estrogen receptors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2031350

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.